Tatva Chintan Pharma Makes A Stellar Debut, Lists At 95% Premium
Thursday, July 29, 2021
Comment
Tatva Chintan Pharma IPO was subscribed by a whopping 180.36 times, receiving bids for over 58.83 crore shares against the total issue size of over 32.61 lakh shares
from NDTV Profit - Latest https://ift.tt/3BQefyD
from NDTV Profit - Latest https://ift.tt/3BQefyD
0 Response to "Tatva Chintan Pharma Makes A Stellar Debut, Lists At 95% Premium"
Post a Comment